 PETACH TIKVA, Israel, March 01, 2022 GLOBE NEWSWIRE -- PolyPid Ltd. Nasdaq: PYPD, PolyPid or the Company, a Phase 3 biopharmaceutical company focused on developing targeted, locally administered, and prolonged-release therapeutics using its proprietary PLEX technology, today announced that it will present at the Barclays Global Healthcare Conference, which is being held in Miami, Florida, on March 15-17, 2022. 